LFCR — LIFECORE BIOMEDICAL, INC. \DE\
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1005286 ·
Last close
$6.39
Market Cap
$242.22M
52W High
$8.98
52W Low
$3.63
ADV30
446,362
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 25,322,000 | 6,826,000 | -894,000 | -40,084,000 | 228,303,000 | 23,035,000 | 301,707,000 |
| Jun 2026 | 34,167,000 | 12,075,000 | 2,567,000 | -6,156,000 | 229,500,000 | 17,241,000 | 263,594,000 |
| Mar 2026 | 23,193,000 | 4,462,000 | -4,672,000 | -14,980,000 | 225,499,000 | 20,795,000 | 253,937,000 |
| Sep 2025 | 31,109,000 | 7,791,000 | -3,067,000 | -9,991,000 | 235,204,000 | 18,856,000 | 245,741,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$11,219,000
Investing CF
$-4,280,000
Financing CF
$-2,736,000
CapEx
$-4,280,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.99
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-284,421,000
Inventory
$27,695,000
Receivables
$31,347,000
ST Investments
—
EBIT TTM
$-41,178,000
Pretax Income TTM
$-70,761,000
Interest Exp TTM
$29,583,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$106,460,592
EBITDA
$4,168,287
Free Cash Flow
—
Enterprise Value
$431,353,184
Total Cash
$23,035,000
Total Debt
$162,179,008
Shares Out
37,905,846
Trailing EPS
$-1.27
Book Value
$-1.94
ROE
—
ROA
—
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | 232,177,000 | 246,379,000 | -14,202,000 | — |
| May 2025 | 128,867,000 | -12,006,000 | -38,717,000 | 239,342,000 | 238,006,000 | 1,336,000 | -206,000 |
| May 2024 | 128,261,000 | -7,188,000 | 12,013,000 | 253,960,000 | 242,645,000 | 11,315,000 | 257,000 |
| May 2023 | 103,269,000 | -19,720,000 | -99,563,000 | 253,545,000 | 257,775,000 | -4,230,000 | -17,441,000 |
| May 2022 | 111,270,000 | -3,432,000 | -116,715,000 | — | — | — | -22,593,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$229,500,000
Forward EPS
$-0.78
Max Pain — expiry 2026-12-18
max pain strike: $5.00 · spot: $6.40 · call oi: 2,140 · put oi: 658
Expected Move to 2026-12-18:
±$1.15
(17.97%) —
implied range
$5.25 –
$7.55
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRE | Prenetics Global Ltd | $248.19M | $16.33 | — |
| RCKT | ROCKET PHARMACEUTICALS, INC. | $235.60M | $2.11 | — |
| BIOA | BioAge Labs, Inc. | $234.35M | $5.10 | — |
| NWBO | NORTHWEST BIOTHERAPEUTICS INC | $250.73M | $0.15 | — |
| CAMP | Camp4 Therapeutics Corp | $251.02M | $4.00 | — |
News headlines (Yahoo Finance, 1h cache)
Lifecore Biomedical: Q3 Earnings Snapshot
2026-11-04 12:27 · Yahoo
Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
2026-11-04 12:05 · Yahoo
Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing?
2026-10-23 17:34 · Yahoo
Lifecore Biomedical to Participate at Upcoming Industry Conferences
2026-10-07 20:05 · Yahoo
Lifecore Biomedical to be Acquired by Webster Equity Partners
2026-09-28 12:45 · Yahoo
Lifecore Biomedical to Participate at CPHI Global Conference
2026-09-03 20:05 · Yahoo
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
2026-09-02 11:05 · Yahoo
Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity
2026-08-17 15:29 · Yahoo
Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript
2026-08-12 15:31 · Yahoo
Lifecore Biomedical Inc (LFCR) (Q2 2026) Earnings Call Highlights: Strategic Wins and Capacity ...
2026-08-05 19:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.